Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Jun;103(2):1399–1406. doi: 10.1111/j.1476-5381.1991.tb09801.x

Naloxone-induced cardiovascular depression in rats that had received chronic morphine-treatment.

S Dai 1, Y Wang 1
PMCID: PMC1908344  PMID: 1715795

Abstract

1. Cardiovascular changes in response to intravenous injection of naloxone were studied in pentobarbitone-anaesthetized rats which had been given morphine in their drinking water for 1-21 days. The mechanisms of the observed changes were investigated in intact animals and in isolated hearts and tail arteries. 2. In rats that had received chronic morphine-treatment, intravenous administration of naloxone caused immediate decreases in blood pressure, heart rate, left ventricular pressure and dLVP/dtmax which were followed by the occurrence of atrial or ventricular extrasystoles and other signs of opiate withdrawal such as faecal passage and muscle twitching. 3. The intensities of the naloxone-precipitated cardiovascular changes were directly related to the duration of chronic morphine pretreatment, reaching statistically significant levels on day 2 or 3 and maximal levels on day 7 or 14. This phenomenon disappeared on days 3 to 14 following opiate withdrawal in animals which had been treated previously with morphine for 21 days. 4. Either atropine or clonidine pretreatment significantly prevented the occurrence of faecal passage or muscle twitching during naloxone-precipitated opiate withdrawal. However, clonidine, but not atropine or yohimbine, abolished the decreases in various haemodynamic parameters. The occurrence of cardiac extrasystoles was not affected. 5. In isolated heart or tail artery preparations from chronically morphine-treated rats, naloxone administration did not elicit reactions which differed from those of the preparations from naive animals. These findings suggest that under pentobarbitone anaesthesia, the cardiovascular systems of rats that had received chronic morphine treatment exhibit inhibitory, instead of excitatory, reactions to naloxone-precipitated opiate withdrawal.

Full text

PDF
1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altura B. M., Altura B. T., Carella A., Turlapaty P. D., Weinberg J. Vascular smooth muscle and general anesthetics. Fed Proc. 1980 Apr;39(5):1584–1591. [PubMed] [Google Scholar]
  2. Badawy A. A., Evans C. M., Evans M. Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br J Pharmacol. 1982 Mar;75(3):485–491. doi: 10.1111/j.1476-5381.1982.tb09165.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buccafusco J. J. Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine. Pharmacol Biochem Behav. 1983 Feb;18(2):209–215. doi: 10.1016/0091-3057(83)90365-9. [DOI] [PubMed] [Google Scholar]
  4. Byrd L. D. Cardiovascular effects of naloxone, naltrexone and morphine in the squirrel monkey. Life Sci. 1983 Jan 24;32(4):391–398. doi: 10.1016/0024-3205(83)90085-1. [DOI] [PubMed] [Google Scholar]
  5. Chang E. B., Brown D. R., Field M., Miller R. J. An antiabsorptive basis for precipitated withdrawal diarrhea in morphine-dependent rats. J Pharmacol Exp Ther. 1984 Feb;228(2):364–369. [PubMed] [Google Scholar]
  6. Dai S. Histamine enhances hypoxia-induced ventricular arrhythmias in isolated rat hearts. Clin Exp Pharmacol Physiol. 1989 Dec;16(12):925–931. doi: 10.1111/j.1440-1681.1989.tb02403.x. [DOI] [PubMed] [Google Scholar]
  7. Ehrenpreis S., Greenberg J., Comaty J. E. Mechanism of development of tolerance to injected morphine by guinea pig ileum. Life Sci. 1975 Jul 1;17(1):49–54. doi: 10.1016/0024-3205(75)90233-7. [DOI] [PubMed] [Google Scholar]
  8. Fielding S., Wilker J., Hynes M., Szewczak M., Novick W. J., Jr, Lal H. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J Pharmacol Exp Ther. 1978 Dec;207(3):899–905. [PubMed] [Google Scholar]
  9. Gold M. S., Redmond D. E., Jr, Kleber H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978 Sep 16;2(8090):599–602. doi: 10.1016/s0140-6736(78)92823-4. [DOI] [PubMed] [Google Scholar]
  10. Holaday J. W. Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol. 1983;23:541–594. doi: 10.1146/annurev.pa.23.040183.002545. [DOI] [PubMed] [Google Scholar]
  11. Ko W. W., Dai S., Chan M. Y. Cardiovascular responses to acute myocardial ischaemia in morphine-dependent rats. Clin Exp Pharmacol Physiol. 1988 Jan;15(1):23–31. doi: 10.1111/j.1440-1681.1988.tb01005.x. [DOI] [PubMed] [Google Scholar]
  12. Kromer W., Woinoff R. Peristalsis in the isolated guinea-pig ileum during opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol. 1980 Nov;314(2):191–193. doi: 10.1007/BF00504537. [DOI] [PubMed] [Google Scholar]
  13. Labrecque G., Domino E. F. Tolerance to and physical dependence on morphine: relation to neocortical acetylcholine release in the cat. J Pharmacol Exp Ther. 1974 Oct;191(1):189–200. [PubMed] [Google Scholar]
  14. Leung C. M., Ogle C. W., Dai S. Production of physical dependence in rats by drinking a morphine solution. Pharmacol Biochem Behav. 1986 Nov;25(5):1001–1006. doi: 10.1016/0091-3057(86)90077-8. [DOI] [PubMed] [Google Scholar]
  15. Marshall D. C., Buccafusco J. J. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat. J Neurosci. 1987 Mar;7(3):621–628. doi: 10.1523/JNEUROSCI.07-03-00621.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Simantov Rabi, Childers S. R., Snyder S. H. (3H) Opiate binding: anomalous properties in kidney and liver membranes. Mol Pharmacol. 1978 Jan;14(1):69–76. [PubMed] [Google Scholar]
  17. WIKLER A., FRASER H. F., ISBELL H. N-Allylnormorphine: effects of single doses and precipitation of acute abstinence syndromes during addiction to morphine; methadone or heroin in man (post addicts). J Pharmacol Exp Ther. 1953 Sep;109(1):8–20. [PubMed] [Google Scholar]
  18. Wong-Dusting H. K., Rand M. J. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Eur J Pharmacol. 1985 Apr 23;111(1):65–72. doi: 10.1016/0014-2999(85)90114-1. [DOI] [PubMed] [Google Scholar]
  19. Xiao X. H., Rand M. J. Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery. Br J Pharmacol. 1989 Mar;96(3):539–546. doi: 10.1111/j.1476-5381.1989.tb11851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES